These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35989899)

  • 1. The repeat length of
    Tang L; Chen L; Liu X; He J; Ma Y; Zhang N; Fan D
    Front Neurol; 2022; 13():939775. PubMed ID: 35989899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.
    Narain P; Gomes J; Bhatia R; Singh I; Vivekanandan P
    Neurobiol Aging; 2017 Aug; 56():211.e9-211.e14. PubMed ID: 28527524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.
    Chiò A; Mora G; Sabatelli M; Caponnetto C; Lunetta C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Trojsi F; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Riva N; Carrera P; Giannini F; Mandrioli J; Tanel R; Capasso M; Tremolizzo L; Battistini S; Murru MR; Origone P; Zollino M; Penco S; ; ; Mazzini L; D'Alfonso S; Restagno G; Brunetti M; Barberis M; Conforti FL
    Neurobiol Aging; 2016 Mar; 39():218.e5-8. PubMed ID: 26733254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical and Polynucleotide Repeat Expansion Analysis of
    Hou X; Li W; Liu P; Liu Z; Yuan Y; Ni J; Shen L; Tang B; Wang J
    Front Neurol; 2022; 13():811202. PubMed ID: 35599735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis.
    Chiò A; Moglia C; Canosa A; Manera U; Grassano M; Vasta R; Palumbo F; Gallone S; Brunetti M; Barberis M; De Marchi F; Dalgard C; Chia R; Mora G; Iazzolino B; Peotta L; Traynor BJ; Corrado L; D'Alfonso S; Mazzini L; Calvo A
    Neurology; 2023 Jul; 101(1):e83-e93. PubMed ID: 37202167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.
    Lattante S; Millecamps S; Stevanin G; Rivaud-Péchoux S; Moigneu C; Camuzat A; Da Barroca S; Mundwiller E; Couarch P; Salachas F; Hannequin D; Meininger V; Pasquier F; Seilhean D; Couratier P; Danel-Brunaud V; Bonnet AM; Tranchant C; LeGuern E; Brice A; Le Ber I; Kabashi E;
    Neurology; 2014 Sep; 83(11):990-5. PubMed ID: 25098532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate-length CAG repeat expansions in Ataxin-2 does not have 1C2-positive polyglutamine inclusions.
    Highley JR; Lorente Pons A; Cooper-Knock J; Wharton SB; Ince PG; Shaw PJ; Wood J; Kirby J
    Neuropathol Appl Neurobiol; 2016 Jun; 42(4):377-89. PubMed ID: 26095883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating
    Jih KY; Lin KP; Tsai PC; Soong BW; Liao YC; Lee YC
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug; 22(5-6):442-447. PubMed ID: 33377399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism.
    Zhang M; Xi Z; Misquitta K; Sato C; Moreno D; Liang Y; Slow E; Rogaeva E; Tartaglia MC
    Mov Disord; 2017 Jan; 32(1):158-162. PubMed ID: 28124431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis.
    Neuenschwander AG; Thai KK; Figueroa KP; Pulst SM
    JAMA Neurol; 2014 Dec; 71(12):1529-34. PubMed ID: 25285812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions.
    Tan RH; Kril JJ; McGinley C; Hassani M; Masuda-Suzukake M; Hasegawa M; Mito R; Kiernan MC; Halliday GM
    Ann Neurol; 2016 Feb; 79(2):295-305. PubMed ID: 26599997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate Repeat Expansion in the
    Borrego-Hernández D; Vázquez-Costa JF; Domínguez-Rubio R; Expósito-Blázquez L; Aller E; Padró-Miquel A; García-Casanova P; Colomina MJ; Martín-Arriscado C; Osta R; Cordero-Vázquez P; Esteban-Pérez J; Povedano-Panadés M; García-Redondo A
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.
    Yu Z; Zhu Y; Chen-Plotkin AS; Clay-Falcone D; McCluskey L; Elman L; Kalb RG; Trojanowski JQ; Lee VM; Van Deerlin VM; Gitler AD; Bonini NM
    PLoS One; 2011 Mar; 6(3):e17951. PubMed ID: 21479228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of ATXN2 trinucleotide repeats in Korean patients with amyotrophic lateral sclerosis.
    Kim YE; Oh KW; Noh MY; Park J; Kim HJ; Park JE; Ki CS; Kim SH
    Neurobiol Aging; 2018 Jul; 67():201.e5-201.e8. PubMed ID: 29665996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype.
    Rutherford NJ; Heckman MG; Dejesus-Hernandez M; Baker MC; Soto-Ortolaza AI; Rayaprolu S; Stewart H; Finger E; Volkening K; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Knopman DS; Kretzschmar HA; Neumann M; Caselli RJ; White CL; Mackenzie IR; Petersen RC; Strong MJ; Miller BL; Boeve BF; Uitti RJ; Boylan KB; Wszolek ZK; Graff-Radford NR; Dickson DW; Ross OA; Rademakers R
    Neurobiol Aging; 2012 Dec; 33(12):2950.e5-7. PubMed ID: 22840558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 levels in the brain tissue of ALS cases with and without
    Yang Y; Halliday GM; Kiernan MC; Tan RH
    Neurology; 2019 Nov; 93(19):e1748-e1755. PubMed ID: 31619481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis.
    Liu X; Lu M; Tang L; Zhang N; Chui D; Fan D
    Neurobiol Aging; 2013 Sep; 34(9):2236.e5-8. PubMed ID: 23635656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72-ALS.
    Laffita-Mesa JM; Nennesmo I; Paucar M; Svenningsson P
    Mov Disord; 2021 Feb; 36(2):508-514. PubMed ID: 33058338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate-length CAG repeat in ATXN2 is associated with increased risk for amyotrophic lateral sclerosis in Brazilian patients.
    Tavares de Andrade HM; Cintra VP; de Albuquerque M; Piccinin CC; Bonadia LC; Duarte Couteiro RE; Sabino de Oliveira D; Claudino R; Magno Gonçalves MV; Dourado MET; de Souza LC; Teixeira AL; de Godoy Rousseff Prado L; Tumas V; Bulle Oliveira AS; Nucci A; Lopes-Cendes I; Marques W; França MC
    Neurobiol Aging; 2018 Sep; 69():292.e15-292.e18. PubMed ID: 29934271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway.
    Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E
    Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.